With a decade of product development funded by awards from the National Institutes of Health (NIH), Gateway Biotechnology has been developing drug candidates to combat hearing disorders. Our innovative approach, grounded in a deep understanding of basic mechanisms underlying hearing loss, targets multiple cellular pathways with new product formulations that fine-tune drug delivery to the ear. Our lead candidates demonstrate great efficacy in preventing and treating tinnitus.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Drug that treats tinnitus
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):